This is not the most recent version of the article. View current version (11 JAN 2014)

Intervention Protocol

Trifluoperazine versus placebo for schizophrenia

  1. Kai Koch1,*,
  2. Kamel Mansi2,
  3. Euan Haynes2,
  4. Clive E Adams2

Editorial Group: Cochrane Schizophrenia Group

Published Online: 14 NOV 2012

DOI: 10.1002/14651858.CD010226


How to Cite

Koch K, Mansi K, Haynes E, Adams CE. Trifluoperazine versus placebo for schizophrenia (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD010226. DOI: 10.1002/14651858.CD010226.

Author Information

  1. 1

    The University of Nottingham, Department of Medicine, Nottingham, UK

  2. 2

    The University of Nottingham, Cochrane Schizophrenia Group, Nottingham, UK

*Kai Koch, Department of Medicine, The University of Nottingham, Medical School, Queens Medical School, Nottingham, NG7 2UH, UK. mzydkuk@nottingham.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 14 NOV 2012

SEARCH

This is not the most recent version of the article. View current version (11 JAN 2014)

  1. You have free access to this content

    Current Version

    Trifluoperazine versus placebo for schizophrenia

    Kai Koch, Kamel Mansi, Euan Haynes, Clive E Adams, Stephanie Sampson and Vivek A Furtado

    Version of Record online: 11 JAN 2014 | DOI: 10.1002/14651858.CD010226.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Trifluoperazine versus placebo for schizophrenia

    Kai Koch, Kamel Mansi, Euan Haynes and Clive E Adams

    Version of Record online: 14 NOV 2012 | DOI: 10.1002/14651858.CD010226